Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 8.176 Q1 | 254 | 26 | 65 | 10316 | 1412 | 65 | 22.15 | 396.77 | |
2 | Drug Resistance Updates | journal | 4.010 Q1 | 132 | 27 | 52 | 6312 | 868 | 52 | 17.80 | 233.78 | |
3 | Medicinal Research Reviews | journal | 2.868 Q1 | 150 | 81 | 162 | 16520 | 2023 | 160 | 12.29 | 203.95 | |
4 | Pharmacology and Therapeutics | journal | 3.461 Q1 | 233 | 151 | 450 | 30790 | 5501 | 450 | 11.71 | 203.91 | |
5 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.730 Q2 | 82 | 18 | 43 | 2951 | 201 | 43 | 4.93 | 163.94 | |
6 | Current Neuropharmacology | journal | 1.955 Q1 | 103 | 78 | 283 | 11625 | 2008 | 257 | 6.61 | 149.04 | |
7 | Annual Review of Pharmacology and Toxicology | journal | 4.968 Q1 | 224 | 33 | 90 | 4408 | 1273 | 90 | 13.16 | 133.58 | |
8 | Current Medicinal Chemistry | journal | 0.934 Q2 | 202 | 382 | 1048 | 47291 | 4223 | 959 | 3.80 | 123.80 | |
9 | Interdisciplinary Toxicology | journal | 0.297 Q3 | 38 | 6 | 74 | 725 | 102 | 74 | 1.12 | 120.83 | |
10 | Expert Opinion on Therapeutic Targets | journal | 1.964 Q1 | 106 | 103 | 291 | 12152 | 1629 | 257 | 5.41 | 117.98 | |
11 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 29 | 7 | 25 | 793 | 51 | 0 | 2.38 | 113.29 | ||
12 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.031 Q2 | 100 | 95 | 323 | 10735 | 1351 | 299 | 4.04 | 113.00 | |
13 | Cellular and Molecular Life Sciences | journal | 2.928 Q1 | 261 | 313 | 876 | 35261 | 7378 | 869 | 8.64 | 112.65 | |
14 | Current Drug Targets | journal | 0.826 Q2 | 119 | 141 | 450 | 15650 | 1540 | 422 | 3.15 | 110.99 | |
15 | Expert Opinion on Emerging Drugs | journal | 0.975 Q2 | 54 | 41 | 78 | 4420 | 273 | 76 | 3.70 | 107.80 | |
16 | Advanced Therapeutics | journal | 0.125 Q4 | 39 | 78 | 155 | 8196 | 862 | 152 | 5.56 | 105.08 | |
17 | Current Pharmaceutical Design | journal | 0.690 Q2 | 183 | 515 | 1637 | 53255 | 5006 | 1517 | 2.78 | 103.41 | |
18 | Pharmacological Research | journal | 1.850 Q1 | 169 | 598 | 1048 | 58728 | 7342 | 971 | 6.90 | 98.21 | |
19 | Mini-Reviews in Medicinal Chemistry | journal | 0.603 Q3 | 107 | 149 | 359 | 14217 | 1277 | 339 | 3.65 | 95.42 | |
20 | Expert Review of Precision Medicine and Drug Development | journal | 0.387 Q3 | 16 | 43 | 115 | 4041 | 151 | 91 | 1.39 | 93.98 | |
21 | Journal of NeuroImmune Pharmacology | journal | 1.219 Q1 | 91 | 69 | 162 | 6473 | 611 | 149 | 3.23 | 93.81 | |
22 | Expert Opinion on Therapeutic Patents | journal | 1.121 Q1 | 88 | 71 | 253 | 6591 | 1462 | 244 | 6.40 | 92.83 | |
23 | CNS and Neurological Disorders - Drug Targets | journal | 0.923 Q2 | 96 | 65 | 287 | 5920 | 1076 | 265 | 3.94 | 91.08 | |
24 | Expert Review of Vaccines | journal | 1.864 Q1 | 105 | 94 | 314 | 8262 | 1569 | 289 | 4.67 | 87.89 | |
25 | Neurotherapeutics | journal | 2.496 Q1 | 136 | 154 | 292 | 13488 | 2091 | 270 | 6.61 | 87.58 | |
26 | Neuropharmacology | journal | 1.760 Q1 | 191 | 417 | 1332 | 35128 | 6810 | 1306 | 4.79 | 84.24 | |
27 | Expert Opinion on Investigational Drugs | journal | 1.410 Q1 | 117 | 132 | 336 | 11059 | 1672 | 321 | 5.10 | 83.78 | |
28 | Current Pharmacology Reports | journal | 0.503 Q3 | 35 | 40 | 122 | 3327 | 221 | 120 | 1.60 | 83.18 | |
29 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.716 Q1 | 150 | 204 | 751 | 16345 | 3626 | 740 | 4.81 | 80.12 | |
30 | Current Cancer Drug Targets | journal | 0.972 Q2 | 103 | 75 | 237 | 5949 | 734 | 219 | 3.13 | 79.32 | |
31 | Current Vascular Pharmacology | journal | 0.806 Q2 | 69 | 76 | 225 | 5973 | 643 | 197 | 2.27 | 78.59 | |
32 | Biomarker Insights | journal | 1.075 Q1 | 40 | 17 | 60 | 1317 | 292 | 59 | 5.85 | 77.47 | |
33 | Expert Opinion on Biological Therapy | journal | 1.088 Q1 | 102 | 149 | 427 | 11491 | 1648 | 395 | 3.80 | 77.12 | |
34 | Pharmacology Biochemistry and Behavior | journal | 1.184 Q1 | 148 | 151 | 366 | 11557 | 1230 | 361 | 3.36 | 76.54 | |
35 | Drug Discovery Today | journal | 1.778 Q1 | 215 | 249 | 666 | 18949 | 5285 | 629 | 7.37 | 76.10 | |
36 | Biochemical Pharmacology | journal | 1.595 Q1 | 220 | 475 | 989 | 35892 | 5635 | 979 | 5.35 | 75.56 | |
37 | PharmaNutrition | journal | 0.548 Q3 | 30 | 57 | 68 | 4231 | 249 | 68 | 2.28 | 74.23 | |
38 | Current Drug Metabolism | journal | 0.667 Q2 | 122 | 115 | 341 | 8505 | 1194 | 308 | 3.52 | 73.96 | |
39 | Expert Opinion on Pharmacotherapy | journal | 0.873 Q2 | 93 | 230 | 647 | 16897 | 1968 | 568 | 3.01 | 73.47 | |
40 | Current Molecular Pharmacology | journal | 0.717 Q2 | 49 | 32 | 89 | 2336 | 258 | 81 | 3.21 | 73.00 | |
41 | Prostaglandins and Other Lipid Mediators | journal | 0.810 Q2 | 86 | 61 | 164 | 4398 | 516 | 163 | 3.07 | 72.10 | |
42 | British Journal of Pharmacology | journal | 2.432 Q1 | 244 | 364 | 1008 | 26207 | 7736 | 951 | 7.18 | 72.00 | |
43 | BioDrugs | journal | 1.919 Q1 | 79 | 62 | 166 | 4406 | 981 | 155 | 4.90 | 71.06 | |
44 | Asian Journal of Pharmaceutical Sciences | journal | 1.021 Q2 | 66 | 60 | 189 | 4210 | 1146 | 187 | 6.62 | 70.17 | |
45 | Phytotherapy Research | journal | 1.019 Q2 | 158 | 264 | 723 | 18424 | 3888 | 712 | 5.59 | 69.79 | |
46 | Trends in Pharmacological Sciences | journal | 3.878 Q1 | 244 | 101 | 288 | 6920 | 3228 | 276 | 10.11 | 68.51 | |
47 | European Journal of Medicinal Chemistry | journal | 1.177 Q1 | 203 | 843 | 2846 | 56864 | 17485 | 2844 | 6.26 | 67.45 | |
48 | Current Cardiovascular Risk Reports | journal | 0.285 Q3 | 34 | 25 | 106 | 1660 | 69 | 106 | 0.74 | 66.40 | |
49 | Frontiers in Pharmacology | journal | 1.384 Q1 | 154 | 2200 | 3969 | 145595 | 22327 | 3901 | 5.45 | 66.18 | |
50 | Molecular Diagnosis and Therapy | journal | 1.322 Q1 | 68 | 61 | 190 | 3981 | 733 | 183 | 3.74 | 65.26 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®